Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.36%
1,040.69
-3.71
-0.36%
—1,044.401,041.751,048.311,037.77——
SIXC
Communications
SIXC
Communications
SIXC
-1.59%
560.36
-9.05
-1.59%
—569.41569.41569.41558.54——
SIXE
Energy
SIXE
Energy
SIXE
+1.71%
1,317.69
+22.18
+1.71%
—1,295.511,294.951,321.871,289.74——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.27%
1,606.91
-20.60
-1.27%
—1,627.511,623.211,627.281,603.21——
SIXM
Financials
SIXM
Financials
SIXM
-2.49%
590.28
-15.10
-2.49%
—605.38603.79603.79588.51——
SIXR
Staples
SIXR
Staples
SIXR
+0.79%
827.98
+6.50
+0.79%
—821.48822.07833.11819.99——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.68%
197.04
-1.35
-0.68%
—198.39198.39199.10196.67——
SIXT
Technology
SIXT
Technology
SIXT
-1.92%
2,618.20
-51.38
-1.92%
—2,669.582,654.812,660.502,611.26——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.61%
924.66
+5.61
+0.61%
—919.05920.79933.78918.70——
SIXV
Health care
SIXV
Health care
SIXV
-1.71%
1,449.59
-25.17
-1.71%
—1,474.761,475.771,475.771,447.42——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-2.87%
2,136.89
-63.11
-2.87%
—2,200.002,191.332,191.332,132.17——
500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹2,258.40
-2.72%
(-63.20) 1D
Mar 27, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500660...
Open
₹2,300.55
High
₹2,325.90
Low
₹2,257.10
Mkt. cap
383.03B
Avg. vol.
2.83K
Volume
3.76K
Dividend
1.86%
Quarterly dividend
₹10.50
Ex dividend date
May 31, 2024
P/E ratio
37.47
52-wk high
₹3,515.95
52-wk low
₹2,220.00
EPS
₹60.26
Shares outstanding
169.41M
No. of employees
3K
News stories
From sources across the web
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.11K
FoundedNov 13, 1924
Headquarters-
SectorPharmaceutical industry
Websiteindia-pharma.gsk.com
Last report
Feb 9, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -INR
Revenue / Estimate
10.41B/ (10.27B est.)INR
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
9.74B
8.05B
9.80B
10.41B
Cost of goods sold
3.75B
2.88B
3.56B
3.64B
Cost of revenue
3.75B
2.88B
3.56B
3.64B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.75B
1.53B
1.38B
1.52B
Operating expense
2.77B
2.82B
3.06B
3.26B
Total operating expenses
6.52B
5.69B
6.62B
6.90B
Operating income
3.22B
2.36B
3.18B
3.51B
Other non operating income
-1.05B
437.20M
335.70M
321.20M
EBT including unusual items
3.59B
2.79B
3.54B
4.00B
EBT excluding unusual items
2.90B
2.79B
3.51B
3.82B
Income tax expense
956.96M
739.70M
965.10M
1.04B
Effective tax rate
26.69%
26.51%
27.26%
26.08%
Other operating expenses
-126.42M
1.14B
1.51B
1.54B
Net income
2.63B
2.05B
2.57B
2.96B
Net profit margin
26.98%
25.46%
26.28%
28.39%
Earnings per share
54.52
-
-
-
Interest and investment income
762.80M
-
-
-
Interest expense
-5.84M
-4.20M
-5.10M
-11.90M
Net interest expenses
756.96M
-4.20M
-5.10M
-11.90M
Depreciation and amortization charges
147.22M
155.20M
174.30M
203.20M
EBITDA
3.32B
2.45B
3.35B
3.61B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer